Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 18, 1994Proceedings of the National Academy of SciencesOpen Access

An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.

View Full Paper
Ask AI
Bookmark
Share

Authors

CMCathy L. MillerIowa State UniversityJLJ H LeeUniversity of IowaEKE KieffHarvard University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Miller et al. (1994) studied this question.

synapsesocial.com/papers/6a70c7e3a528af2d65c3bb20https://doi.org/10.1073/pnas.91.2.772
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD231990 · 575 citations
  2. 2Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity1988 · 393 citations
  3. 3Two related Epstein-Barr virus membrane proteins are encoded by separate genes1989 · 160 citations
  4. 4The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts1988 · 117 citations
  5. 5Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.1993 · 776 citations